NMC Health founder B.R. Shetty faces $5.4bn fraud trial on 23 March 2026
B.R. Shetty, founder of NMC Health, faces trial on 23 March 2026 for $5.4 billion in fraud. The proceedings mark a shift in UAE healthcare oversight.
Fraud trial begins for B.R. Shetty
Criminal proceedings against B.R. Shetty, the founder of NMC Health, start on 23 March 2026. Prosecutors charge B.R. Shetty with orchestrating a $5.4 billion fraud. The case addresses the collapse of the hospital operator, which was once the largest private provider in the United Arab Emirates.
Regulatory shifts in the United Arab Emirates
The 2020 insolvency of NMC Health forced Department of Health – Abu Dhabi (DoH) and Dubai Health Authority (DHA) officials to change oversight rules. Regulators now require more transparency to stop the balance sheet issues found during the original filing. The trial results will shape how the Ministry of Health and Prevention (MOHAP) reviews financial health for new facility licenses.
- $5.4 billion in debt existed at the time of the collapse.
- 80 financial institutions reported exposure to the debt in 2020.
- NMC OpCo, a new entity, manages operations today.
Financial oversight for healthcare executives
Healthcare executives now face stricter audit standards under the United Arab Emirates regulatory framework. Banking partners require more documentation to satisfy compliance, making capital acquisition for facility development more difficult than in the pre-2020 environment.
The legal proceedings define the boundaries of executive liability within the private healthcare sector, said Aditya Raman, a lead equity analyst at Gulf Financial Insights.
The trial lasts several months, with witness testimony examining the internal reporting mechanisms that allowed the debt to remain hidden. Investors and hospital board members monitor the court to see if new requirements for independent audits of medical groups in Abu Dhabi and Dubai follow the verdict.
Journal Staff
Editorial
Contributing to UAE healthcare industry coverage

